Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
677.56
423.24
270.26
220.18
38.54
0.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
677.56
423.24
270.26
220.18
38.54
0.00
0.00
Raw Material Cost
307.41
189.67
91.04
51.19
14.02
3.81
3.28
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
196.27
168.01
129.43
94.91
83.32
43.92
33.75
Other Expenses
9.67
11.12
7.50
6.43
9.78
10.96
13.29
Total Expenditure (Excl Depreciation)
600.34
468.86
295.45
210.41
195.18
157.36
169.96
Operating Profit (PBDIT) excl Other Income
77.2
-45.599999999999994
-25.2
9.8
-156.6
-157.4
-170
Other Income
11.65
9.46
8.54
1.25
0.10
1.13
6.05
Operating Profit (PBDIT)
90.42
-34.46
-14.54
15.25
-152.45
-152.42
-160.63
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
370.15
233.57
179.22
168.99
24.52
-3.81
-3.28
Depreciation
1.55
1.70
2.11
4.22
4.09
3.81
3.28
Profit Before Tax
88.87
-36.15
-16.65
11.03
-156.54
-156.23
-163.91
Tax
29.86
7.04
-30.74
-172.34
1.39
5.15
-2.05
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
59.01
-43.19
14.08
183.36
-157.92
-161.38
-161.87
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
59.01
-43.19
14.08
183.36
-157.92
-161.38
-161.87
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
59.01
-43.19
14.08
183.36
-157.92
-161.38
-161.87
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
567.61
438.44
438.84
396.15
185.04
311.94
225.42
Earnings per share (EPS)
0.75
-0.6
0.2
2.6
-2.3
-2.61
-2.99
Diluted Earnings per share
0.75
-0.6
0.2
2.6
-2.3
-2.61
-2.99
Operating Profit Margin (Excl OI)
11.4%
-10.78%
-9.32%
4.44%
-406.38%
0.0%
0.0%
Gross Profit Margin
13.35%
-8.14%
-5.38%
6.92%
-395.53%
0.0%
0.0%
PAT Margin
8.71%
-10.21%
5.21%
83.28%
-409.72%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 60.11% vs 56.57% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 236.57% vs -406.38% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 279.50% vs -90.04% in Dec 2024
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Kiniksa Pharmaceuticals International Plc With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
677.56
0
677.56
Other Operating Income
0.00
0.00
0.00
Total Operating income
677.56
0
677.56
Raw Material Cost
307.41
0
307.41
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
196.27
0
196.27
Other Expenses
9.67
0.00
9.67
Total Expenditure (Excl Depreciation)
600.34
0
600.34
Operating Profit (PBDIT) excl Other Income
77.22
0.00
77.22
Other Income
11.65
0
11.65
Operating Profit (PBDIT)
90.42
0
90.42
Interest
0.00
0
0.00
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
370.15
0
370.15
Depreciation
1.55
0
1.55
Profit Before Tax
88.87
0
88.87
Tax
29.86
0
29.86
Provisions and contingencies
0
0
0.00
Profit After Tax
59.01
0
59.01
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
59.01
0
59.01
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
59.01
0
59.01
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
567.61
0
567.61
Earnings per share (EPS)
0.75
0
0.75
Diluted Earnings per share
0.75
0
0.75
Operating Profit Margin (Excl OI)
11.40%
0%
0.00
11.40%
Gross Profit Margin
13.35%
0%
0.00
13.35%
PAT Margin
8.71%
0%
0.00
8.71%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 67.76 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 60.11% vs 56.57% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 5.90 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 236.57% vs -406.38% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.88 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 279.50% vs -90.04% in Dec 2024
Annual - Interest
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.40%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






